物质使用和精神障碍的综合治疗。
Integrated treatment of substance use and psychiatric disorders.
机构信息
The Center for Psychiatric and Chemical Dependency Services, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA.
出版信息
Soc Work Public Health. 2013;28(3-4):388-406. doi: 10.1080/19371918.2013.774673.
Abstract
Epidemiological studies find that psychiatric disorders, including mental disorders and substance use disorders, are common among adults and highly comorbid. Integrated treatment refers to the focus of treatment on two or more conditions and to the use of multiple treatments such as the combination of psychotherapy and pharmacotherapy. Integrated treatment for comorbidity has been found to be consistently superior compared to treatment of individual disorders with separate treatment plans. This article focuses on a review of the risks for developing comorbid disorders and the combinations of treatments that appear to be most effective for clients with particular comorbid disorders.
摘要
流行病学研究发现，精神障碍包括精神障碍和物质使用障碍，在成年人中很常见，且高度共病。综合治疗是指治疗的重点是两种或两种以上的疾病，并使用多种治疗方法，如心理治疗和药物治疗的结合。与针对单独疾病的单独治疗计划相比，针对共病的综合治疗一直被发现具有一致性的优越性。本文重点回顾了共病障碍的发展风险，以及针对特定共病障碍患者似乎最有效的治疗组合。
相似文献
1
Integrated treatment of substance use and psychiatric disorders.
Soc Work Public Health. 2013;28(3-4):388-406. doi: 10.1080/19371918.2013.774673.
2
Treatment of substance abusing patients with comorbid psychiatric disorders.
Addict Behav. 2012 Jan;37(1):11-24. doi: 10.1016/j.addbeh.2011.09.010. Epub 2011 Sep 14.
3
Psychological interventions for co-occurring depression and substance use disorders.
Cochrane Database Syst Rev. 2019 Nov 26;2019(11):CD009501. doi: 10.1002/14651858.CD009501.pub2.
4
Integrated versus parallel treatment of co-occurring psychiatric and substance use disorders.
J Subst Abuse Treat. 2006 Jan;30(1):79-84. doi: 10.1016/j.jsat.2005.10.004.
5
Managing psychiatric comorbidity within versus outside of methadone treatment settings: a randomized and controlled evaluation.
Addiction. 2013 Nov;108(11):1942-51. doi: 10.1111/add.12269. Epub 2013 Jul 19.
6
Treatment of dual diagnosis disorders.
Curr Opin Psychiatry. 2012 May;25(3):194-200. doi: 10.1097/YCO.0b013e328351a3e0.
7
[Comorbidity of substance use and other psychiatric disorders--theoretical foundation and evidence based therapy].
Fortschr Neurol Psychiatr. 2008 May;76(5):263-71. doi: 10.1055/s-2008-1038154.
8
[Dual diagnosis psychosis and substance use disorders in adolescents--part 2].
Fortschr Neurol Psychiatr. 2010 Feb;78(2):90-100. doi: 10.1055/s-0028-1109979. Epub 2010 Feb 9.
9
Psychosocial interventions for the long-term management of patients with severe mental illness and co-occurring substance use disorder.
J Clin Psychiatry. 2006;67 Suppl 7:10-7.
10
Randomized control trial of an integrated therapy for comorbid anger and gambling.
Psychother Res. 2008 Jul;18(4):454-65. doi: 10.1080/10503300701858362.
引用本文的文献
1
Factors associated with non-adherence to clinic visits among patients with severe mental illness enrolled in the SMILE study in Uganda.
BMC Psychiatry. 2025 Jul 29;25(1):734. doi: 10.1186/s12888-025-07121-7.
2
Neurobiological Mechanisms of Action of Transcranial Direct Current Stimulation (tDCS) in the Treatment of Substance Use Disorders (SUDs)-A Review.
J Clin Med. 2025 Jul 10;14(14):4899. doi: 10.3390/jcm14144899.
3
Comprehensive Review on Association of Bipolar Disorder and Substance Abuse: Dual Diagnosis and Treatment Approaches.
Cureus. 2025 Jun 19;17(6):e86363. doi: 10.7759/cureus.86363. eCollection 2025 Jun.
4
Prevalence and Temporal Trends of Mental Disorders in Persons with Opioid Use Disorder and Concurrent Mental Disorders in British Columbia, Canada, Using Population-Level Administrative Data, 2013 to 2021: Prévalence et tendances temporelles des troubles mentaux chez les personnes souffrant d'un trouble lié à la consommation d'opioïdes et de troubles mentaux concomitants en Colombie-Britannique, au Canada, à partir de données administratives au niveau de la population, entre 2013 et 2021.
Can J Psychiatry. 2025 Jun 9:7067437251347150. doi: 10.1177/07067437251347150.
5
Impact of Co-Occurring Psychiatric Comorbidities and Substance Use Disorders on Outcomes in Adolescents and Young Adults with Opioid Use Disorder: A Retrospective Cohort Study.
Pharmaceuticals (Basel). 2025 Apr 23;18(5):609. doi: 10.3390/ph18050609.
6
Posttraumatic Stress Disorder Symptoms Moderate the Association between Childhood Sexual Abuse and Compulsive Sexual Behavior Among Adults in Residential Substance Use Treatment.
Arch Sex Behav. 2025 Apr;54(4):1527-1536. doi: 10.1007/s10508-025-03123-4. Epub 2025 Apr 2.
7
Relationship between social support and substance use among American Indian people with a self-identified substance use problem.
Cultur Divers Ethnic Minor Psychol. 2025 Mar 24. doi: 10.1037/cdp0000743.
8
Clients' Experiences and Satisfaction with an Integrated Intensive Outpatient Program for Substance Use Disorders.
Actas Esp Psiquiatr. 2025 Mar;53(2):340-347. doi: 10.62641/aep.v53i2.1835.
9
Representative national survey on drug use during the COVID-19 stay-at-home order in the USA.
BMJ Open. 2025 Mar 7;15(3):e086141. doi: 10.1136/bmjopen-2024-086141.
10
Transcriptional impacts of substance use disorder and HIV on human ventral midbrain neurons and microglia.
bioRxiv. 2025 Feb 8:2025.02.05.636667. doi: 10.1101/2025.02.05.636667.
本文引用的文献
1
The addictive brain: all roads lead to dopamine.
J Psychoactive Drugs. 2012 Apr-Jun;44(2):134-43. doi: 10.1080/02791072.2012.685407.
2
Measures of substance consumption among substance users, DSM-IV abusers, and those with DSM-IV dependence disorders in a nationally representative sample.
J Stud Alcohol Drugs. 2012 Sep;73(5):820-8. doi: 10.15288/jsad.2012.73.820.
3
Longitudinal twin study of borderline personality disorder traits and substance use in adolescence: developmental change, reciprocal effects, and genetic and environmental influences.
Personal Disord. 2013 Jan;4(1):23-32. doi: 10.1037/a0027178. Epub 2012 May 28.
4
A review of the interactions between alcohol and the endocannabinoid system: implications for alcohol dependence and future directions for research.
Alcohol. 2012 May;46(3):185-204. doi: 10.1016/j.alcohol.2012.01.002. Epub 2012 Mar 27.
5
Neuroanatomy of dopamine: reward and addiction.
J Neuropsychiatry Clin Neurosci. 2012 Winter;24(1):1-4. doi: 10.1176/appi.neuropsych.24.1.1.
6
Managing patients with dual diagnosis in psychiatric practice.
Curr Opin Psychiatry. 2012 May;25(3):201-5. doi: 10.1097/YCO.0b013e3283523d3d.
7
Treatment of dual diagnosis disorders.
Curr Opin Psychiatry. 2012 May;25(3):194-200. doi: 10.1097/YCO.0b013e328351a3e0.
8
Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907.
Neuropsychopharmacology. 2012 May;37(6):1465-73. doi: 10.1038/npp.2011.332. Epub 2012 Feb 22.
9
The addicted brain craves new neurons: putative role for adult-born progenitors in promoting recovery.
Trends Neurosci. 2012 Apr;35(4):250-60. doi: 10.1016/j.tins.2011.12.005. Epub 2012 Jan 19.
10
Prevalence and impact of substance use among emerging adults with serious mental health conditions.
Psychiatr Rehabil J. 2012 Winter;35(3):235-43. doi: 10.2975/35.3.2012.235.243.
Zotero 插件